AMPLY Discovery combines machine learning engines with physical wet labs to build a closed-loop platform targeting hard-to-treat diseases.
What it is
AMPLY Discovery is a biotechnology platform that combines computational machine learning engines with physical laboratory validation to target the uncharted regions of the genome. The system connects six specialized machine learning engines with two wet-lab hubs to translate computational predictions into validated therapeutic programs against critical diseases.
Key features
- Integrates six specialized machine learning engines for target discovery, triage, and therapeutic design into a closed-loop workflow.
- Utilizes the HALLUX engine for atlas-scale cancer non-coding RNA target exploration and dependency scoring.
- Employs the MtG and siREN engines for gapmer antisense and cytoplasmic RNA interference therapeutic design.
- Features THEBOX browser-native primer design suite for custom primer creation and validation.
- Includes FOLIO for antimicrobial biologics design.
- Combines computational models with physical wet-lab validation in Belfast and London.
Who it's for
AMPLY Discovery is built for pharmaceutical partners, biotech collaborators, and research teams developing targeted therapeutics for oncology and drug-resistant infections.
Pricing
Check the official website for current pricing.
Use cases
- Design gapmer antisense oligonucleotides
Similar to AMPLY Discovery
More AMPLY Discovery alternatives
Aqemia
AI AgentsPhysics-driven AI for drug invention workflows
Aqemia applies generative AI and physics-based modeling through its proprietary QEMI platform to design novel drug candidates from first principles.
